Understanding and treating ER-positive breast cancer

The way that a doctor treats ER-positive breast cancer depends on many factors, including the stage of cancer, how much it has spread, and the source of cancer. If the cancer is ER- or PR-positive, hormone therapy will almost certainly be included in the treatment plan for the patient.

Understanding Post-Treatment “Chemobrain”

Although these are all small studies, together they point to imbalances or deficits in neurotransmitter activity as risk factors for cognitive impairment after cancer treatment, a conclusion that could have a variety of treatment implications. For example, research shows that in animal models, the antidepressant fluoxetine can prevent or improve memory problems associated with the chemotherapy treatment 5-FU.

The Truth About Progesterone and Breast Cancer

Hormone receptor-positive breast cancers have many hormone receptors. When breast cancer develops, the tumor cells become overly sensitive to estrogen. When estrogen activates the estrogen receptor, it turns on a panel of genes that tell the cells to keep dividing, driving tumor growth. However, when breast cancer cells have working progesterone receptors, and there is sufficient progesterone available, progesterone will slow down estrogen fueled growth and division of these cells.

Black Women Still Far Less Likely to Get Immediate Breast Reconstruction

“Since these large databases play an important role in making healthcare policy, it’s important to appreciate the significant differences in racial and socioeconomic disparities in immediate breast reconstruction,” senior author Samuel J. Lin, MD, MBA, of Harvard Medical School, and a member of the American Society of Plastic Surgeons, said in a press release.

Royal Rife and a ‘virus’ at the heart of every cancer?

This article covers the work of Royal Rife, a scientist who could well have been at least 80 years ahead of his time. Not only did he invent one of the most powerful microscopes ever seen, he used it to identify foreign matter, which he called a ´virus´, at the heart of every cancer. He then went on to work out the energetic frequency of each of the different ´viruses´ he found and even build a ´Rife Machine´, or colloquially a zapper, which could adjust electrofrequency and kill off that particular ´virus´ leaving healthy cells untouched. He was ridiculed, attacked and his work stopped. He died a pauper. Only now are scientists once again thinking there might be an infection contributing to every cancer, as Big Pharma contemplates the profits involved in developing a myriad of vaccines.

Breast cancer risk slashed by Rainbow Diet

A colourful Mediterranean Diet, or a Rainbow Diet, can reduce the risk of post-menopausal breast cancer by 40 per cent, according to research by the World Cancer Research Fund. It was particularly effective at reducing non-estrogen positive breast cancers (ER-) like Triple Negative Breast Cancer and HER2+ Breast Cancer, which have been increasing and now account for a third of all newly diagnosed breast cancers.

Is Bisphenol S Just as Risky as Bisphenol A?

Replacing BPA in common products allows manufacturers to claim their goods are BPA-free. It doesn’t mean that the plastics, receipts or paper currency containing replacement compounds are safe. Bisphenol S, or BPS, is one of the most widely used replacements. Testing in breast cancer cells shows, however, that BPS also mimics estrogen and is an endocrine disruptor.

How Does Bisphenol A (BPA) Affect Breast Cancer? 

Scientists at Duke University have found that this endocrine-disrupting compound can make inflammatory breast cancer cells resist treatment. When these cancer cells are treated with bisphenol A in the laboratory, they generate more of the signaling molecules called epidermal growth factor receptors. A low dose of BPA doubled the amount of EGFR on cell surfaces. As a result of exposure to BPA, these aggressive breast cancer cells grew faster and were less likely to die when treated with common anti-cancer drugs. A response of this nature could complicate treatment of this devastating disease.

How To Fund Your Cancer Treatment

If you have been diagnosed with cancer and decide to pursue a natural or integrative protocol, traditional insurance policies may not cover the cost of treatments. In this case, there are options to help ensure that everyday financial responsibilities do not become overwhelming.

10 Revolutionary Life Lessons from Studying Cancer Survivors

Kelly Turner studies cancer patients who have been told they had only months to live, that there was nothing more that could be done, and yet are walking around cancer-free years later. She calls these cases radical remissions — instead of spontaneous remissions, as they are more commonly referred to — because what she has learned from analyzing more than 1,000 (out of an estimated 100,000) of these cases is that there are common threads among the behaviors of the people who have radical remissions.

Breast Cancer Aftermath: Cutting Through the Brain Fog(s)

Maybe it is because I am getting older? Whatever it is, more research needs to be done. It is really frustrating and embarrassing, too. But I can say this: Things have started to get better. It has been months since I had a major memory obstacle. However, I still find some trouble getting my words out. And for those who are still battling chemo brain, please know it will get better. I know it is frustrating. Hopefully, in time it will go away. But I honestly think I always will have some of it left in me.

Preventive tools for women at high risk for breast cancer 

Some women are more prone to getting breast cancer than others. Knowing your risk may prove empowering, especially at a time when prevention efforts are growing in both importance and availability. With today’s focus on preventing cancer when possible, some medical leaders are designing programs specifically to identify high-risk women and help them avoid becoming the one in eight women who will be diagnosed with breast cancer in her lifetime.

Novel Approaches in Male Breast Cancer

Male breast cancer (MBC) is a rare and poorly understood disease, but recent molecular studies have revealed fundamental differences from female breast cancer that could help guide treatment strategies toward a more tailored approach

Killer: Cancer or Chemo?

A recent analysis found that cancer drugs are themselves killing up to 50% of patients within thirty days, indicating that chemotherapy was the cause of death, not the cancer. Of course, chemotherapy can kill patients over the long-term as well. Chemo can shrink tumors, but it doesn’t eradicate them. It also kills healthy cells in the process. Additionally, cancer can re-emerge in patients still undergoing chemotherapy. Researchers think this is because tumors are fueled by cancer “stem cells” that are largely immune to chemo. It is also incredibly expensive for the consumer (which is key for the drug companies), costing around $10,000 a month.

More Breast Cancer Patients Than Previously Thought Could Benefit from PARP Inhibitors

PARP inhibitors like Lynparza (olaparib) were designed to treat patients with inherited BRCA1 or BRCA2 mutations, but more women with breast cancer could benefit from these drugs, a study suggests. The team found that up to 22 percent of breast cancer patients had mutations that led to a defective BRCA function — a much higher percentage than the 1 to 5 percent of women known to have BRCA mutations. While the results must be validated in future clinical trials, the findings suggest that a much larger percentage of breast cancer patients could benefit from already approved PARP inhibitors.